Loading…
← CockpitCompetitor Analysis › RDC.DE Redcare Pharmacy N.V.Open in the cockpit ↗

Redcare Pharmacy N.V.RDC.DECompetitor analysis, valuation and peers

Germany · EUR·Health Care›Medical Distributors

German-Dutch online pharmacy selling prescription and over-the-counter medicines and health products across Europe.

≈ A European Amazon Pharmacy/GoodRx hybridMomentum leader 90
Mkt cap
$1.50B
US dollars, full cap
Free float
73%
of shares outstanding
$/day
$4.80M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-9.2 pp
WACC 9.6%
Hurdle
n/a
no reverse DCF
Next earnings
105 days
3 Mar 2027
Close · EUR€66.50
1D-2.3%
1W-6.5%
1M-12.4%
3M+7.4%
6M+53.1%
YTD+2.1%
1Y+6.7%
ATR %4.9%
52w lowhigh16.8% off high

What Redcare Pharmacy does

German-Dutch online pharmacy selling prescription and over-the-counter medicines and health products across Europe.

Sells medicines and health products shipped from central warehouses, with the non-prescription range carrying most revenue and prescriptions growing since Germany made electronic prescriptions mandatory in 2024. Germany is the largest market. The company is based in the Netherlands and was formerly named Shop Apotheke Europe.

In one line: A European Amazon Pharmacy/GoodRx hybrid.

Products and services

  • Prescription medicine delivery (e-Rx)
  • OTC/health & beauty products
  • Pharmacy app/loyalty programs

Customers

  • Consumers across Germany, Netherlands, other EU ma

Where it sits in the supply chain

  • Health Care
  • Online pharmacy/e-commerce
  • Prescription & OTC medicine e-commerce

What could go right

  • German e-prescription rollout driving online pharmacy adoption
  • Cross-border EU e-commerce growth

What could go wrong

  • Regulatory changes to pharmacy/e-Rx rules
  • Competition from Amazon and incumbent pharmacy chains

Moat: narrow (scale, brand, regulatory licence). First-mover scale in German e-prescription market and pharmacy licences, but faces new entrants as e-Rx opens up.

Headquarters: Sevenum, Netherlands / Cologne, Germany · Founded: 2000 · Employees: 2,649

Named competitors

  • Zur Rose/DocMorris private or unlisted
  • Amazon Pharmacy AMZN
  • Apotea (private) private or unlisted

Redcare Pharmacy at a glance

Size Redcare Pharmacy (RDC.DE) is a Germany Health Care company (Medical Distributors) with a market value of $1.50B, the 121st largest of 198 Germany companies the cockpit tracks. Shares closed at €66.50 on 18 Nov 2026.

Performance Over six months the shares gained 53.1%, against +1.4% for the median peer and -0.9% for the Germany market (cap-weighted) — 3rd highest of 21 in its peer set.

Growth Revenue grew 18.6% over the last twelve months (peer median +5.5%); the operating margin is 0.1% (peer median 3.2%).

Valuation It trades at 0.5× enterprise value to sales against a peer median of 0.5× (10th cheapest of 21).

Capital Return on invested capital runs 9.2 points below its cost of capital (9.6% WACC).

Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).

Relative performance

10015021 May 202621 Aug 202618 Nov 2026RDC.DE 151Peer median 103
Six months, rebased to 100: Redcare Pharmacy against the median of its 20 peers (local-currency closes).

Redcare Pharmacy financials

Reported figures in EUR; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue€3.34B€2.94B€2.37B€1.80B€1.20B
Revenue growth—+24%+32%+49%—
Gross profit€645M€594M€478M€383M€292M
EBITDA€78.0M€45.6M€28.9M€40.5M-€15.3M
Net income-€34.0M-€37.7M-€45.5M-€12.0M-€77.6M
Free cash flow-€20.4M-€56.3M€11.4M€51.8M-€49.4M
Capital expenditure€93.4M€119M€42.2M€38.2M€53.5M
Total debt€354M€416M€278M€275M€241M

Quarterly statements and history in the cockpit →

Redcare Pharmacy competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%+40%+60%0%+20%336081296005877476DOCM301584600713603368ARJO-B9987ENTERO6826008930ASKER3349AMP7459RDC.DE6-month return →1-month return →
Up and to the right = strong over both horizons. Redcare Pharmacy is the large dot.

Fundamentals: revenue growth against valuation

0%+5%+10%+15%+20%0×1×2×336081296005877476DOCM301584600713603368ARJO-B9987ENTERO6826008930ASKERNEU3349AMP2733RDC.DERevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Redcare Pharmacy is the large dot.

Redcare Pharmacy competitors and peer comparison

Head to head with its named competitors (RDC.DE vs AMZN)
CompanyMarket cap6M returnRevenue growthOp. marginEV / SalesReq g
Redcare Pharmacy RDC.DE$1.50B+53%+19%0%0.5×n/a
Amazon AMZN$2.90T+1%+15%13%3.9×n/a

How Redcare Pharmacy compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Redcare Pharmacy against its 20 peers (data as of 18 Nov 2026)
MeasureRDC.DEPeer medianRank in peer set
1-month return-12.4%+0.8%lowest of 21
6-month return+53.1%+1.4%3rd highest of 21
Distance from 52-week high-16.8%-17.8%10th highest of 21
Revenue growth (TTM)+18.6%+5.5%2nd highest of 21
Operating margin0.1%3.2%3rd lowest of 21
EV / Sales0.5×0.5×10th cheapest of 21
ROIC minus cost of capital-9.2 pp+1.7 pp2nd lowest of 21
Net debt / EBITDA2.9×0.8×most indebted of 15

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Redcare Pharmacy RDC.DEGermany$1.50B+53%+19%0%0.5×n/an/a
Ship Healthcare 3360.TJapan$1.38B+19%+6%3%0.2×-14.5%+7.6%
Toho 8129.TJapan$1.64B-5%+4%1%0.1×-4.6%+5.1%
Shinva Medical Instrument 600587.SSChina$1.10B-10%+6%5%0.6×-6.9%+1.2%
AS ONE 7476.TJapan$1.10B+25%+10%12%1.3×0.0%+6.3%
DocMorris DOCM.SWSwitzerland$1.08B+169%+11%-8%1.0×n/an/a
Shanghai C and D INNOSTIC Medical Technology 301584.SZChina$1.06B-33%+8%3%0.5×-2.7%+17.9%
Nanjing Pharmaceutical 600713.SSChina$999M-2%+3%2%0.3×n/an/a
Guangxi LiuYao 603368.SSChina$975M+1%+2%5%0.4×-9.7%+6.0%
Arjo ARJO-B.STSweden$974M+42%0%8%1.3×-1.0%+3.9%
Suzuken 9987.TJapan$2.36B+8%+5%1%0.1×-10.4%+3.2%
Entero Healthcare Solutions ENTERO.NSIndia$925M+60%+35%4%1.2×24.7%+29.9%
Shanghai Haohai Biological Technology 6826.HKHong Kong$897M-24%-5%-2%1.9×17.0%+12.4%
Hanmi Science 008930.KSSouth Korea$2.58B+48%+6%4%2.5×26.0%+9.6%
Asker Healthcare ASKER.STSweden$2.69B-14%+12%7%1.8×4.7%+12.7%
Alfresa 2784.TJapan$2.81B-3%+4%1%0.1×-8.4%+3.5%
Neuca NEU.WAPoland$795M-9%+8%2%0.3×5.3%+8.1%
COSMOS Pharmaceutical 3349.TJapan$3.21B+2%+9%4%0.5×n/an/a
Amplifon AMP.MIItaly$3.39B+8%0%10%1.7×6.8%+9.8%
MEDIPAL 7459.TJapan$3.70B+15%+4%1%0.1×-7.2%+3.5%
Arata 2733.TJapan$576M-3%+3%1%0.1×-6.2%+3.8%

Questions

Who are Redcare Pharmacy's main competitors?
Named competitors: Zur Rose/DocMorris (private or unlisted), Amazon Pharmacy (AMZN), Apotea (private) (private or unlisted). The cockpit's measured peer set (industry) also includes Ship Healthcare (3360.T), Toho (8129.T), Shinva Medical Instrument (600587.SS), AS ONE (7476.T), DocMorris (DOCM.SW), Shanghai C and D INNOSTIC Medical Technology (301584.SZ).
Is Redcare Pharmacy expensive compared with its peers?
On ev / sales it trades at 0.5× against a peer median of 0.5×, 10th cheapest of 21 in its peer set.
How has Redcare Pharmacy stock performed?
Over six months to 18 Nov 2026 the shares returned +53.1% against +1.4% for the median peer; over one year +6.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.